Editorial
Published on 05 May 2023
Editorial: Therapeutic targeting of splicing variants in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1206342
- 959 views
Type at least 3 characters
2,216 articles
Articles
Original Research
Published on 05 May 2023
Basic and clinical study of efficacy and adverse effects of flumatinib in Ph+ ALL
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1178393
- 1,584 views
Original Research
Published on 05 May 2023
An ultrasound assisted, ionic liquid-molecular iodine synergy driven efficient green synthesis of pyrrolobenzodiazepine-triazole hybrids as potential anticancer agents
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1168566
- 1,434 views
- 3 citations
Original Research
Published on 05 May 2023
Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1185380
- 1,363 views
Original Research
Published on 05 May 2023
Pyroptosis-related genes prognostic model for predicting targeted therapy and immunotherapy response in soft tissue sarcoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188473
- 1,492 views
- 1 citation
Review
Published on 04 May 2023
Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1143361
- 1,507 views
- 1 citation
Original Research
Published on 04 May 2023
A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1187700
- 1,206 views
Review
Published on 04 May 2023
Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1140771
- 2,209 views
Original Research
Published on 04 May 2023
A pan-cancer analysis of the expression and molecular mechanism of DHX9 in human cancers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1153067
- 3,315 views
- 2 citations
Correction
Published on 03 May 2023
Corrigendum: Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1201715
- 1,033 views
Review
Published on 03 May 2023
Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1002296
- 2,485 views
Review
Published on 03 May 2023
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1174330
- 2,005 views
Correction
Published on 03 May 2023
Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1207589
- 580 views
Original Research
Published on 02 May 2023
A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1038457
- 1,464 views
Systematic Review
Published on 02 May 2023
Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1155163
- 3,273 views
- 2 citations
Original Research
Published on 28 Apr 2023
Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1105427
- 2,381 views
- 2 citations